Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Tanabe

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Oncology|August 23, 2008
A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601)Norisuke Nakayama, Wasaburo Koizumi, Tohru Sasaki, et al.
Surgical Endoscopy|August 26, 2017
Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissectionTakafumi Yano, Kenji Ishido, Satoshi Tanabe, et al.
Journal of Applied Clinical Medical Physics|September 30, 2025
Pre-irradiation dose requirements for reference-class ionization chambers: Quantifying measurement stabilityTakumi Yamada, Kazuki Mayumi, Satoshi Tanabe, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|March 14, 2013
Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinomaChikatoshi Katada, Manabu Muto, Satoshi Tanabe, et al.
Head & Neck|March 8, 2019
Usefulness of narrow band imaging with magnifying endoscopy for the differential diagnosis of cancerous and noncancerous laryngeal lesionsHiroshi Hosono, Chikatoshi Katada, Tabito Okamoto, et al.
Journal of Gastrointestinal Cancer|April 19, 2022
Evaluation of Prognostic Factors for Unresectable or Recurrent Gastric Cancer Treated with NivolumabKenji Ishido, Satoshi Tanabe, Chikatoshi Katada, et al.
World Journal of Gastroenterology|October 20, 2012
Argon plasma coagulation for superficial esophageal squamous-cell carcinoma in high-risk patientsKumiko Tahara, Satoshi Tanabe, Kenji Ishido, et al.
World Journal of Gastroenterology|January 1, 2014
DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomachTakuya Wada, Satoshi Tanabe, Kenji Ishido, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2)Katsuhiko Higuchi, Shouko Komori, Satoshi Tanabe, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2007
P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosisHiroyuki Mitomi, Yasuo Ohkura, Naoshi Fukui, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Oncology|August 23, 2008
A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601)Norisuke Nakayama, Wasaburo Koizumi, Tohru Sasaki, et al.
Surgical Endoscopy|August 26, 2017
Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissectionTakafumi Yano, Kenji Ishido, Satoshi Tanabe, et al.
Journal of Applied Clinical Medical Physics|September 30, 2025
Pre-irradiation dose requirements for reference-class ionization chambers: Quantifying measurement stabilityTakumi Yamada, Kazuki Mayumi, Satoshi Tanabe, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|March 14, 2013
Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinomaChikatoshi Katada, Manabu Muto, Satoshi Tanabe, et al.
Head & Neck|March 8, 2019
Usefulness of narrow band imaging with magnifying endoscopy for the differential diagnosis of cancerous and noncancerous laryngeal lesionsHiroshi Hosono, Chikatoshi Katada, Tabito Okamoto, et al.
Journal of Gastrointestinal Cancer|April 19, 2022
Evaluation of Prognostic Factors for Unresectable or Recurrent Gastric Cancer Treated with NivolumabKenji Ishido, Satoshi Tanabe, Chikatoshi Katada, et al.
World Journal of Gastroenterology|October 20, 2012
Argon plasma coagulation for superficial esophageal squamous-cell carcinoma in high-risk patientsKumiko Tahara, Satoshi Tanabe, Kenji Ishido, et al.
World Journal of Gastroenterology|January 1, 2014
DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomachTakuya Wada, Satoshi Tanabe, Kenji Ishido, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2)Katsuhiko Higuchi, Shouko Komori, Satoshi Tanabe, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2007
P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosisHiroyuki Mitomi, Yasuo Ohkura, Naoshi Fukui, et al.
Pageof 19